According to Sutro Biopharma's latest financial reports the company's current revenue (TTM) is ₹14.20 B. In 2023 the company made a revenue of ₹12.79 B an increase over the revenue in the year 2022 that were of ₹5.60 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.